Fingerprint
Dive into the research topics of 'Phase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of low-dose oral Clofarabine in myelodysplastic syndromes patients who have failed frontline therapy
Venkatesh K. Rudrapatna, Kimberly Morley, Kenneth M. Boucher, Andrew S. Pierson, Christian T. Shull, James P. Kushner, Paul J. Shami
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations